CANESTEN*DERMAL POWDER 1FL 30G 1%

Canesten 1% cutaneous powder
clotrimazole

What it is and what it is used for
Canesten contains clotrimazol, which is an antimycotic (antifungal) for dermatological use, meaning it acts locally by eliminating skin fungi.

Canesten powder is used for the treatment of moist mycoses (fungal infections) of the skin and skin folds, especially when located in covered or poorly ventilated areas (e.g., tinea pedis or athlete's foot, tinea cruris, tinea inguinalis).

What you need to know before taking the medicine
Do not use Canesten
- if you are allergic to clotrimazole or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions
Talk to your doctor or pharmacist before using Canesten if you have previously suffered from these conditions (recurrent mycoses).

The use of non-breathable diapers after applying the medicine for diaper dermatitis is not recommended.
Avoid contact with eyes. Do not swallow.
The use, especially prolonged use, of products for cutaneous use (applied to the skin) can lead to sensitization phenomena such as erythema (localized redness in the area of the skin where the medicine is applied) and itching. In such cases, discontinue treatment and consult your doctor or pharmacist.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported with Canesten, their frequency is not known:
Immune system disorders: angioedema (swelling), anaphylactic reaction, hypersensitivity
Vascular disorders: hypotension (low blood pressure), syncope
Respiratory, thoracic and mediastinal disorders: shortness of breath Skin and subcutaneous tissue disorders: blisters, contact dermatitis, erythema (redness of the skin), paresthesia, skin peeling (loss of cells from the outermost layer of the skin), itching, skin rash, urticaria, stinging pain in the skin, burning sensation in the skin.
Systemic disorders and conditions at the administration site: irritation at the application site, reaction at the application site, oedema, pain.

Following the instructions in the leaflet reduces the risk of side effects.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.